Donor selection for patients undergoing allogeneic hematopoietic SCT: assessment of the priorities of Canadian hematopoietic SCT physicians

about

RhD and haematopoietic transplantation.Unrelated donor choices for allogeneic hematopoietic cell transplantation in Canada: an evaluation of factors influencing donor selection.

P2860

Q42750149-01627D38-4756-4AE6-A400-7AE5D38D5B3A Q47560151-0B4E2DAB-15F1-4F72-9994-0E10EF9402BD

P2860

Donor selection for patients undergoing allogeneic hematopoietic SCT: assessment of the priorities of Canadian hematopoietic SCT physicians

Item

http://www.wikidata.org/entity/Q58056485

description

article

@en

im Juli 2012 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в липні 2012

@uk

name

Donor selection for patients u ...... n hematopoietic SCT physicians

@en

Donor selection for patients u ...... n hematopoietic SCT physicians

@nl

type

Item

label

Donor selection for patients u ...... n hematopoietic SCT physicians

@en

Donor selection for patients u ...... n hematopoietic SCT physicians

@nl

prefLabel

Donor selection for patients u ...... n hematopoietic SCT physicians

@en

Donor selection for patients u ...... n hematopoietic SCT physicians

@nl

P1476

Donor selection for patients u ...... n hematopoietic SCT physicians

@en

P2093

A Tinmouth

http://www.w3.org/2001/XMLSchema#string

P Hébert

http://www.w3.org/2001/XMLSchema#string

P2860

Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantation

Impact of declining fertility rates in Canada on donor options in blood and marrow transplantation.

Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China.

Influence of donor cytomegalovirus (CMV) status on severity of viral reactivation after allogeneic stem cell transplantation in CMV-seropositive recipients.

Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studies.

Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.

Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis.

P2888

bmt.2012.137

P304

314-316

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2012.137

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Doug Coyle

David S. Allan

Jason Tay

P577

2012-07-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22858509

http://www.w3.org/2001/XMLSchema#string

Donor selection for patients undergoing allogeneic hematopoietic SCT: assessment of the priorities of Canadian hematopoietic SCT physicians

about

P2860

P2860

Donor selection for patients undergoing allogeneic hematopoietic SCT: assessment of the priorities of Canadian hematopoietic SCT physicians

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698